BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 21263067)

  • 1. Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7.1 in allogeneic recipients.
    Yi T; Li X; Yao S; Wang L; Chen Y; Zhao D; Johnston HF; Young JS; Liu H; Todorov I; Forman SJ; Chen L; Zeng D
    J Immunol; 2011 Mar; 186(5):2739-49. PubMed ID: 21263067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory and conventional CD4+ T cells show differential effects correlating with PD-1 and B7-H1 expression after immunotherapy.
    Alderson KL; Zhou Q; Berner V; Wilkins DE; Weiss JM; Blazar BR; Welniak LA; Wiltrout RH; Redelman D; Murphy WJ
    J Immunol; 2008 Mar; 180(5):2981-8. PubMed ID: 18292520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity.
    Phares TW; Ramakrishna C; Parra GI; Epstein A; Chen L; Atkinson R; Stohlman SA; Bergmann CC
    J Immunol; 2009 May; 182(9):5430-8. PubMed ID: 19380790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7H1-Ig fusion protein activates the CD4+ IFN-gamma receptor+ type 1 T regulatory subset through IFN-gamma-secreting Th1 cells.
    Ding Q; Lu L; Wang B; Zhou Y; Jiang Y; Zhou X; Xin L; Jiao Z; Chou KY
    J Immunol; 2006 Sep; 177(6):3606-14. PubMed ID: 16951320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloimmune response results in expansion of autoreactive donor CD4+ T cells in transplants that can mediate chronic graft-versus-host disease.
    Zhao D; Young JS; Chen YH; Shen E; Yi T; Todorov I; Chu PG; Forman SJ; Zeng D
    J Immunol; 2011 Jan; 186(2):856-68. PubMed ID: 21149609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of programmed death 1 ligands by murine T cells and APC.
    Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
    J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
    Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism.
    Blazar BR; Carreno BM; Panoskaltsis-Mortari A; Carter L; Iwai Y; Yagita H; Nishimura H; Taylor PA
    J Immunol; 2003 Aug; 171(3):1272-7. PubMed ID: 12874215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-H1 expression on old CD8+ T cells negatively regulates the activation of immune responses in aged animals.
    Mirza N; Duque MA; Dominguez AL; Schrum AG; Dong H; Lustgarten J
    J Immunol; 2010 May; 184(10):5466-5474. PubMed ID: 20375308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of B7-H1 in immune privilege of the eye.
    Hori J
    J Nippon Med Sch; 2008 Feb; 75(1):56-7. PubMed ID: 18360084
    [No Abstract]   [Full Text] [Related]  

  • 11. B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses.
    Lin PY; Sun L; Thibodeaux SR; Ludwig SM; Vadlamudi RK; Hurez VJ; Bahar R; Kious MJ; Livi CB; Wall SR; Chen L; Zhang B; Shin T; Curiel TJ
    J Immunol; 2010 Sep; 185(5):2747-53. PubMed ID: 20686128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.
    Yi T; Chen Y; Wang L; Du G; Huang D; Zhao D; Johnston H; Young J; Todorov I; Umetsu DT; Chen L; Iwakura Y; Kandeel F; Forman S; Zeng D
    Blood; 2009 Oct; 114(14):3101-12. PubMed ID: 19602708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells.
    Kryczek I; Wei S; Zou L; Zhu G; Mottram P; Xu H; Chen L; Zou W
    J Immunol; 2006 Jul; 177(1):40-4. PubMed ID: 16785496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival.
    Shen L; Jin Y; Freeman GJ; Sharpe AH; Dana MR
    J Immunol; 2007 Sep; 179(6):3672-9. PubMed ID: 17785803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.
    Lucas JA; Menke J; Rabacal WA; Schoen FJ; Sharpe AH; Kelley VR
    J Immunol; 2008 Aug; 181(4):2513-21. PubMed ID: 18684942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta.
    Wei S; Shreiner AB; Takeshita N; Chen L; Zou W; Chang AE
    Cancer Res; 2008 Jul; 68(13):5432-8. PubMed ID: 18593946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.
    Yamazaki T; Akiba H; Koyanagi A; Azuma M; Yagita H; Okumura K
    J Immunol; 2005 Aug; 175(3):1586-92. PubMed ID: 16034097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections].
    Taylor PA; Lees CJ; Fournier S; Allison JP; Sharpe AH; Blazar BR
    J Immunol; 2004 Jan; 172(1):34-9. PubMed ID: 14688306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.
    Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I
    J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.